The effect of highly active antiretroviral therapy on outcome of central nervous system herpesviruses infection in Cuban human immunodeficiency virus-infected individuals

Journal of NeuroVirology

Volumn 13, Issue 5, 2007, Pages 446-451

  Martínez, Pedro Ariel ^a   Díaz, René ^a   González, Daniel ^a   Oropesa, Lisset ^a   González, Ruby ^a   Pérez, Lissette ^a   Viera, Jenniffer ^a   Kourí, Vivian ^a  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

Author keywords

AIDS; Cuban; Encephalitis; Herpesviruses; HIV

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID EXAMINATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CUBA; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; ENCEPHALITIS; EPSTEIN BARR VIRUS; FEMALE; FEVER; HEADACHE; HERPES SIMPLEX VIRUS; HERPES VIRUS INFECTION; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VARICELLA ZOSTER VIRUS; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS VIRULENCE; VOMITING;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CENTRAL NERVOUS SYSTEM DISEASES; CUBA; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HERPESVIRUS 6, HUMAN; HUMANS; ODDS RATIO; POLYMERASE CHAIN REACTION;

CYTOMEGALOVIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS; SIMPLEXVIRUS;

EID: 36148944324     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280701510088     Document Type: Article

References (43)

1. Bernstein, W. B., Little, R. F., Wilson, W. H. and Yarchon, R. (2006) Acquiredimmunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy. Int J Hematol, 84, pp. 3-11.
2. Boivin, G. (2004) Diagnosis of herpesvirus infections of the central nervous system. HERPES, 11, pp. 48A-56A.
3. Brink, N. S., Sharvell, Y., Howard, M. R., Fox, J. D., Harrison, M. J. and Miller, R. F. (1998) Detection of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus DNA in CSF from persons infected with HIV who had neurological disease. J Neurol Neurosurg Psychiatry, 65, pp. 191-195.
4. Broccolo, F., Iuliano, R., Careddu, A. M., Trovato, R., Lico, S., Blanc, P. L., Mazzotta, F. and Ceccherini-Nelli, L. (2000) Detection of lymphotropic herpesvirus DNA by polymerase chain reaction in cerebrospinal fluid of AIDS patients with neurological disease. Acta Virol, 44, pp. 137-143.
5. Brodt, H. R., Kamps, B. S., Gute, P., Knupp, B., Staszewski, S. and Helm, E. B. (1997) Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS, 11, pp. 1731-1738.
6. Centers for Disease Control and Prevention (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep, 41, pp. 1-19.
7. Chaudhuri, A. and Kennedy, P. G. (2002) Diagnosis and treatment of viral encephalitis. Postgrad Med J, 78, pp. 575-583.
8. Corti, M., Villafañe, F., Trione, N., Schtirbu, R., Yampolsky, C. and Narbaitz, M. (2004) Primary central nervous system lymphomas in AIDS patients. Enferm Infect Microbiol Clin, 22, pp. 332-336.
9. d'Arminio, M. A., Duca, P. G., Vago, L., Grassi, M. P. and Moroni, M. (2000) Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy. Neurology, 54, pp. 1856-1859.
10. Deayton, J. R. and Griffiths, P. D. (2000) When can cytomegalovirus prophylaxis and maintenance therapy be stopped in HIV disease?. Curr Opin Infect Dis, 13, pp. 637-641.
11. DeBiasi, R. L. and Tyler, K. L. (2004) Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev, 17, pp. 903-925.
12. Dewhurst, S. (2004) Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system. HERPES, 11, pp. 105A-111A.
13. Eza, D., Cerrillo, G., Moore, D. A., Castro, C., Ticona, E., Morales, D., Cabanillas, J., Barrantes, F., Alfaro, A., Benavides, A., Rafael, A., Valladares, G., Arevalo, F., Evans, C. A. and Gilman, R. H. (2006) Postmortem findings and opportunistic infections in HIV-positive patients from a public hospital in Peru. Pathol Res Pract, 202, pp. 767-775.
14. Fica, A., Pérez, C., Reyes, P. O., Gallardo, S. P., Calvo, X. P. and Salinas, A. (2005) Herpetic encephalitis. Case series of 15 patients confirmed by polymerase chain reaction. Rev Chil Infect, 22, pp. 38-46.
15. French, M. A., Price, P. and Stone, S. F. (2004) Immune restoration disease after antiretroviral therapy. AIDS, 18, pp. 1615-1627.
16. Gerna, G., Piccinini, G., Genini, E., Percivalle, E., Zavattoni, M., Lilleri, D., Testa, L., Comolli, G., Maserati, R., Baldanti, F., Maccario, R., Monforte, A. D. and Revello, M. G. (2001) Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART. J Acquir Immune Defic Syndr, 28, pp. 320-331.
17. Glaser, C. A., Gilliam, S., Schnurr, D., Forghani, B., Honarmand, S., Khetsuriani, N., Fischer, M., Cossen, C. K. and Anderson, L. J. (2003) In search of encephalitis etiologies: Diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis, 36, pp. 731-742.
18. Griffiths, P. (2004) Cytomegalovirus Infection of the Central Nervous System. HERPES, 11, pp. 95A-104A.
19. Keane, N. M., Price, P., Lee, S., Almeida, C. A., Stone, S. F., James, I. and French, M. A. (2004) Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy. HIV Med, 5, pp. 407-414.
20. Kennedy, P. G. (2005) Viral encephalitis. J Neurol, 252, pp. 268-272.
21. Kourí, V., Resik, S., Tenorio, A., Suárez, C. and García, S. (2000) Meningoencefalitis por virus de la familia herpesviridae en Cuba. Período 1996-1998. Rev Argent Microbiol, 32, pp. 77-82.
22. Lee, T. C., Tsai, C. P., Yuan, C. L., Wei, C. Y., Tsao, W. L., Lee, R. J., Cheih, S. Y., Huang, I. T. and Chen, K. T. (2003) Encephalitis in Taiwan: A prospective hospital-based study. Jpn J Infect Dis, 56, pp. 193-199.
23. Mamidi, A., De Simone, J. A. and Pomerantz, R. J. (2002) Central nervous system infections in individuals with HIV-1 infection. J NeuroVirol, 8, pp. 158-167.
24. Maschke, M., Kastrup, O., Esser, S., Ross, B., Hengge, U. and Hufnagel, A. (2000) Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry, 69, pp. 376-380.
25. McGrath, N., Anderson, N. E., Croxson, M. C. and Powell, K. F. (1997) Herpes simplex encephalitis treated with acyclovir: Diagnosis and long term outcome. J Neurol Neurosurg Psychiatry, 63, pp. 321-326.
26. Michaels, J. and the Adult Spectrum of Disease Cohort (1998) Opportunistic incidence rates from the Tulane/adult spectrum of disease cohort, 1994-8. Presented at the Fifth Conference on Retroviruses and Opportunistic Infections Chicago
27. Minjolle, S., Arvieux, C., Gautier, A. L., Jusselin, I., Thomas, R., Michelet, C. and Colimon, R. (2002) Detection of herpesvirus genomes by polymerase chain reaction in cerebrospinal fluid and clinical findings. J Clin Virol, 25, pp. S59-S70.
28. Neuenburg, J. K., Brodt, H. R., Herndier, B. G., Bickel, M., Bacchetti, P., Price, R. W., Grant, R. M. and Schlote, W. (2002) HIV-related neuropathology, 1985 to 1999: Rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr, 31, pp. 171-177.
29. Palella Jr, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J. and Holmberg, S. D. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med, 338, pp. 853-860.
30. Pérez, J., Pérez, D., Gonzalez, I., Jidy, M Diaz, Orta, M., Aragonés, C., Joanes, J., Santín, M., Lantero, M. I., Torres, R., González, A. and Álvarez, A. (2004) Approaches to the management of HIV/AIDS in Cuba
31. Quereda, C., Corral, I., Laguna, F., Valencia, M. E., Tenorio, A., Echeverria, J. E., Navas, E., Martín-Dávila, P., Moreno, A., Moreno, V., Gonzalez-Lahoz, J. M., Arribas, J. R. and Guerrero, A. (2000) Diagnostic utility of a multiplex herpesvirus PCR assay performed with cerebrospinal fluid from human immunodeficiency virus-infected patients with neurological disorders. J Clin Microbiol, 38, pp. 3061-3067.
32. Read, S. J. and Kurt, J. B. (1999) Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay. J Clin Microbiol, 37, pp. 1352-1355.
33. (1996) Herpesvirus infections in the immunocompromised host with HIV-update. Recommendations from the IHMF Management Strategies Workshop and 4th Annual Meeting
34. Skoldenberg, B. (1996) Herpes simplex encephalitis. Scand J Infect Dis Suppl, 100, pp. 8-13.
35. Steiner, I., Budka, H., Chaudhuri, A., Koskiniemi, M., Sainio, K., Salonen, O. and Kennedy, P GE (2005) Viral encephalitis: A review of diagnostic methods and guidelines for management. Eur J Neurol, 12, pp. 331-343.
36. Tang, Y. W., Espy, M. J., Persing, D. H. and Smith, T. F. (1997) Molecular evidence and clinical significance of herpesvirus coinfection in the central nervous system. J Clin Microbiol, 35, pp. 2869-2872.
37. Tenorio, A., Echevarría, J. E., Casas, I., Echevarría, J. M. and Tabarés, E. (1993) Detection and typing of human herpesviruses by multiplex polymerase chain reaction. J Virol Methods, 44, pp. 261-269.
38. Toledo, P. V., Pellegrino, L. N. and Cunha, C. A. (2004) Varicella-zoster virus encephalitis in an AIDS patient. Braz J Infect Dis, 8, pp. 255-258.
39. Tselis, A. and Lavi, E. (2000) Cytomegalovirus infection of the adult nervous system. Infectious diseases of the nervous system, pp. 109-138. Butterworth-Heinemann, Oxford
40. Vago, L., Nebuloni, M., Sala, E., Cinque, P., Bonetto, S., Isella, A., Ottoni, L., Crociati, A. and Costanzi, G. (1996) Coinfection of the central nervous system by cytomegalovirus and herpes simplex virus type 1 or 2 in AIDS patients: Autopsy study on 82 cases by immunohistochemistry and polymerase chain reaction. Acta Neuropathol, 92, pp. 404-408.
41. Weinberg, A., Bloch, K. C., Tang, Y. W., Palmer, M. and Tyler, K. L. (2005) Dual infections of the central nervous system with Epstein-Barr virus. J Infect Dis, 191, pp. 234-237.
42. Yazdanpanah, Y., Chene, G., Losina, E., Goldie, S. J., Merchadou, L. D., Alfandari, S., Seage 3rd, G. R., Sullivan, L., Marimoutou, C., Paltiel, A. D., Salamon, R., Mouton, Y. and Freedberg, K. A. (2001) Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts. Int J Epidemiol, 30, pp. 864-871.
43. Zelman, I. B. and Mossakowski, M. J. (1998) Opportunistic infections of the central nervous system in the course of acquired immune deficiency syndrome (AIDS). Morphological analysis of 172 cases. Folia Neuropathol, 36, pp. 129-144.